Diagnostic Challenges in Choroid Plexus Tumours
In this review, we summarise the diagnostic spectrum of choroid plexus tumours, highlight key age‐dependent differential diagnoses across infants, children/adolescents and adults, and outline how histopathology, immunohistochemistry and molecular profiling support accurate tumour classification.
Christian Thomas, Martin Hasselblatt
wiley +1 more source
Mixed Medullary and Papillary Thyroid Carcinoma in a Patient on Tirzepatide. [PDF]
Beshay LH, Makker J, Ahern S.
europepmc +1 more source
ABSTRACT A 69‐year‐old male patient presented with weight loss and proteinuria. His medical history included papillary thyroid carcinoma. Laboratory findings showed proteinuria and high κ light chain levels in both urine and serum. Bone marrow aspiration revealed plasma cell myeloma of the IgA‐κ type.
Seoyoung Choi, Kyung Chul Moon
wiley +1 more source
Proteomic analysis of papillary thyroid carcinoma in the context of Hashimoto's thyroiditis. [PDF]
Zhou H +8 more
europepmc +1 more source
Secretory Carcinoma Mimicking a Mucocele: Case Report and Literature Update
ABSTRACT Aim Secretory carcinoma (SC), also known as mammary analogue secretory carcinoma, is a rare malignant neoplasm of the salivary glands, named for its histological and molecular resemblance to mammary secretory carcinoma. The aim of this study is to present a new case of SC occurring in the lower lip, initially diagnosed as a mucocele, and to ...
Débora Frota Colares +5 more
wiley +1 more source
Panel-negative strategy for suspected fusion-driven papillary thyroid carcinoma. [PDF]
Okubo Y +7 more
europepmc +1 more source
Malignant struma ovarii with papillary thyroid carcinoma: a case report. [PDF]
Laaboudi R +3 more
europepmc +1 more source
The dual axis of tumorigenesis: MAPK and PI3K/AKT pathways in papillary thyroid carcinoma. [PDF]
Rathod G, Parmar P.
europepmc +1 more source
Evaluation of Dry Eye Parameters in Patients with Papillary Thyroid Carcinoma. [PDF]
Keskin M +9 more
europepmc +1 more source
Periostin promotes papillary thyroid carcinoma progression by modulating mTOR/AKT pathway. [PDF]
Wang S +6 more
europepmc +1 more source

